Ultragenyx Stock Analysis

Ultragenyx Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 6.35. Ultragenyx had not issued any dividends in recent years. The entity had 1:3 split on the 17th of January 2014. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Ultragenyx Pharmaceutical Inc. was incorporated in 2010 and is headquartered in Novato, California. Ultragenyx Pharmaceu operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1119 people. To find out more about Ultragenyx contact the company at 415 483 8800 or learn more at https://www.ultragenyx.com.

Ultragenyx Investment Alerts

Ultragenyx Upcoming and Recent Events

Ultragenyx Largest EPS Surprises

View All Earnings Estimates

Ultragenyx Environmental, Social, and Governance (ESG) Scores

Ultragenyx Stock Institutional Investors

Note, although Ultragenyx's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ultragenyx Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.44 B.

Ultragenyx Profitablity

The company has Profit Margin (PM) of (1.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.95) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.95.

Management Efficiency

Ultragenyx has return on total asset (ROA) of (0.2412) % which means that it has lost $0.2412 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.8998) %, meaning that it created substantial loss on money invested by shareholders. Ultragenyx's management efficiency ratios could be used to measure how well Ultragenyx manages its routine affairs as well as how well it operates its assets and liabilities. As of November 29, 2024, Return On Tangible Assets is expected to decline to -0.5. In addition to that, Return On Capital Employed is expected to decline to -0.49. At present, Ultragenyx's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 20.3 M, whereas Other Current Assets are forecasted to decline to about 34.5 M.

Technical Drivers

As of the 29th of November, Ultragenyx has the Variance of 3.67, risk adjusted performance of (0.1), and Coefficient Of Variation of (754.08). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Ultragenyx, as well as the relationship between them. Please validate Ultragenyx market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Ultragenyx is priced more or less accurately, providing market reflects its prevalent price of 48.13 per share. Given that Ultragenyx has information ratio of (0.20), we advise you to double-check Ultragenyx's current market performance to make sure the company can sustain itself at a future point.

Ultragenyx Price Movement Analysis

Ultragenyx Insider Trading Activities

Ultragenyx Outstanding Bonds

Ultragenyx Predictive Daily Indicators

Ultragenyx Corporate Filings

Ultragenyx Forecast Models

Ultragenyx's time-series forecasting models are one of many Ultragenyx's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ultragenyx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ultragenyx prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ultragenyx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ultragenyx. By using and applying Ultragenyx Stock analysis, traders can create a robust methodology for identifying Ultragenyx entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ultragenyx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ultragenyx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Ultragenyx stock analysis indicators help investors evaluate how Ultragenyx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ultragenyx shares will generate the highest return on investment. By understating and applying Ultragenyx stock analysis, traders can identify Ultragenyx position entry and exit signals to maximize returns.

When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.